Back to STATE STREET CORP STATE STREET CORP

AVIRAVIR
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ATEA PHARMACEUTICALS INC

STATE STREET CORP holds 1.7M shares of AVIR (ATEA PHARMACEUTICALS INC), worth $7.7M as of 2026-Q2. The position was decreased (-2.5% shares). AVIR represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$7.7M

Current Shares

1.7M

Total Value Change

+$1.9M

Total Shares Change

-81,087

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-2.5%
$7.7M0.0%$4.65
0
2026-Q1
Decreased
1.7M
-5.0%
$9.1M0.0%$4.82
0
2025-Q4
Increased
1.8M
+0.0%
$6.4M0.0%$3.55
27
2025-Q3
Increased
1.8M
+0.4%
$5.2M0.0%$2.92
27
2025-Q2
Increased
1.8M
+0.3%
$6.4M0.0%$3.45
27
2025-Q1
Decreased
1.8M
-0.9%
$5.3M0.0%$2.93
0
2024-Q4
Increased
1.8M
+3.0%
$6M0.0%$3.33
28
2024-Q3
Increased
1.7M
+0.7%
$5.8M0.0%$3.44
27

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used